BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32642907)

  • 1. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
    Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
    EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes.
    Blom T; Meinsma R; di Summa F; van den Akker E; van Kuilenburg ABP; Hansen M; Tytgat GAM
    EJNMMI Res; 2021 Aug; 11(1):81. PubMed ID: 34424429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
    Rutgers M; Tytgat GA; Verwijs-Janssen M; Buitenhuis C; Voûte PA; Smets LA
    Int J Cancer; 1993 May; 54(2):290-5. PubMed ID: 8486431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both.
    Tytgat GA; van den Brug MD; Voûte PA; Smets LA; Rutgers M
    Exp Hematol; 2002 Jun; 30(6):555-63. PubMed ID: 12063022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
    Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
    J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine does not interfere with meta-iodobenzylguanidine (MIBG) uptake at clinically relevant concentrations.
    Batra V; Makvandi M; Zuppa AF; Patel N; Elias J; Pryma DA; Maris JM
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27654664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor.
    Oliver KH; Duvernay MT; Hamm HE; Carneiro AM
    J Biol Chem; 2016 Sep; 291(38):20210-9. PubMed ID: 27422820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
    Vaidyanathan G; Welsh PC; Vitorello KC; Snyder S; Friedman HS; Zalutsky MR
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1362-70. PubMed ID: 15205923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
    Zhang H; Huang R; Cheung NK; Guo H; Zanzonico PB; Thaler HT; Lewis JS; Blasberg RG
    Clin Cancer Res; 2014 Apr; 20(8):2182-91. PubMed ID: 24573553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
    Bayer M; Schmitt J; Dittmann H; Handgretinger R; Bruchelt G; Sauter AW
    Nucl Med Biol; 2016 Sep; 43(9):543-551. PubMed ID: 27376201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (
    Grand-Guillaume J; Mansi R; Gaonkar RH; Zanger S; Fani M; Eugster PJ; Beck Popovic M; Grouzmann E; Abid K
    J Transl Med; 2023 Sep; 21(1):604. PubMed ID: 37679770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-iodobenzylguanidine uptake in platelets, megakaryoblastic leukaemia cell lines MKPL-1 and CHRF-28-11 and erythroleukaemic cell line HEL.
    Tytgat GA; Voûte PA; Takeuchi S; Miyoshi I; Rutgers M
    Eur J Cancer; 1995; 31A(4):603-6. PubMed ID: 7576978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
    Lashford LS; Hancock JP; Kemshead JT
    Int J Cancer; 1991 Jan; 47(1):105-9. PubMed ID: 1985865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
    More SS; Itsara M; Yang X; Geier EG; Tadano MK; Seo Y; Vanbrocklin HF; Weiss WA; Mueller S; Haas-Kogan DA; Dubois SG; Matthay KK; Giacomini KM
    Clin Cancer Res; 2011 Apr; 17(8):2339-49. PubMed ID: 21421857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport.
    Roweth HG; Yan R; Bedwani NH; Chauhan A; Fowler N; Watson AH; Malcor JD; Sage SO; Jarvis GE
    Sci Rep; 2018 Feb; 8(1):3494. PubMed ID: 29472624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Novel Antidepressants on Cardiac
    Werner RA; Kobayashi R; Javadi MS; Köck Z; Wakabayashi H; Unterecker S; Nakajima K; Lapa C; Menke A; Higuchi T
    J Nucl Med; 2018 Jul; 59(7):1099-1103. PubMed ID: 29496989
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release.
    Dankoski EC; Carroll S; Wightman RM
    J Neurochem; 2016 Mar; 136(6):1131-1141. PubMed ID: 26749030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
    Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
    Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
    Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR
    Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
    Nackenoff AG; Moussa-Tooks AB; McMeekin AM; Veenstra-VanderWeele J; Blakely RD
    Neuropsychopharmacology; 2016 Jun; 41(7):1733-41. PubMed ID: 26514584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.